[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HN2009000856A - Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. - Google Patents

Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.

Info

Publication number
HN2009000856A
HN2009000856A HN2009000856A HN2009000856A HN2009000856A HN 2009000856 A HN2009000856 A HN 2009000856A HN 2009000856 A HN2009000856 A HN 2009000856A HN 2009000856 A HN2009000856 A HN 2009000856A HN 2009000856 A HN2009000856 A HN 2009000856A
Authority
HN
Honduras
Prior art keywords
pirazols
compositions
contain
replaced
manufacturing
Prior art date
Application number
HN2009000856A
Other languages
English (en)
Inventor
Bjergarde Kirsten
Dodson Mark
Mauger Jacques
Nair Anil
Patek Marcel
Tabart Michel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HN2009000856A publication Critical patent/HN2009000856A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE PRINSIPALMENTE A COMPUESTOS QUIMICOS NUEVOS, PARTICULARMENTE A PIRAZOLES SUSTITUIDOS , A LAS COMPOSICIONES QUE LOS CONTIENEN, Y A SU UTILIZACION COMO MEDICAMENTOS.
HN2009000856A 2006-11-10 2009-05-08 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. HN2009000856A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0609812A FR2908409B1 (fr) 2006-11-10 2006-11-10 Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
HN2009000856A true HN2009000856A (es) 2011-10-19

Family

ID=38169388

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2009000856A HN2009000856A (es) 2006-11-10 2009-05-08 Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.

Country Status (40)

Country Link
US (3) US7989439B2 (es)
EP (1) EP2091920B1 (es)
JP (1) JP5538893B2 (es)
KR (1) KR20090083456A (es)
CN (1) CN101553473B (es)
AR (1) AR063638A1 (es)
AU (1) AU2007327423B2 (es)
BR (1) BRPI0718999A2 (es)
CA (1) CA2667846A1 (es)
CL (1) CL2007003251A1 (es)
CO (1) CO6190516A2 (es)
CR (1) CR10749A (es)
CY (1) CY1116000T1 (es)
DK (1) DK2091920T3 (es)
DO (1) DOP2009000088A (es)
EA (1) EA019454B1 (es)
EC (1) ECSP099312A (es)
ES (1) ES2528385T3 (es)
FR (1) FR2908409B1 (es)
HK (1) HK1137988A1 (es)
HN (1) HN2009000856A (es)
HR (1) HRP20150070T1 (es)
IL (1) IL198328A0 (es)
MA (1) MA30972B1 (es)
MX (1) MX2009004983A (es)
MY (1) MY147502A (es)
NI (1) NI200900078A (es)
NO (1) NO20091990L (es)
NZ (1) NZ576709A (es)
PE (2) PE20121152A1 (es)
PL (1) PL2091920T3 (es)
PT (1) PT2091920E (es)
SI (1) SI2091920T1 (es)
SV (1) SV2009003253A (es)
TN (1) TN2009000155A1 (es)
TW (1) TW200829556A (es)
UA (1) UA97965C2 (es)
UY (1) UY30707A1 (es)
WO (1) WO2008065282A2 (es)
ZA (1) ZA200903560B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858323B2 (en) * 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique
AR079967A1 (es) * 2010-01-26 2012-02-29 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos con oxigeno y su uso como productos farmaceuticos
TWI523844B (zh) 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之３－雜芳醯基胺基－丙酸衍生物及其作為藥物之用途
CN102432639B (zh) * 2011-09-30 2013-11-06 山东大学 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用
MD20150035A2 (ro) 2012-11-02 2015-10-31 Pfizer Inc. Inhibitori de tirozinkinaza Bruton
RU2017134379A (ru) 2015-03-25 2019-04-03 Новартис Аг Формилированные n-гетероциклические производные в качестве ингибиторов fgfr4
CN107619388A (zh) * 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
EP1461334A2 (en) * 2001-04-27 2004-09-29 Vertex Pharmaceuticals Incorporated Pyrazole derived kinase inhibitors
ATE390422T1 (de) * 2003-04-16 2008-04-15 Astrazeneca Ab Quinazolin-derivate für die behandling von krebs
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
MXPA06000794A (es) * 2003-07-22 2006-08-23 Astex Therapeutics Ltd Compuestos 1h-pirazola 3,4-disustituida y su uso como moduladores de quinasas dependientes de ciclina (cdk) y quinasa-3 de sintasa de glicogeno (gsr-3).
US20080004270A1 (en) * 2004-07-05 2008-01-03 Astex Therapeutics Limited 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors
EP1786422A2 (en) * 2004-08-16 2007-05-23 Prosidion Limited Aryl urea derivatives for treating obesity
US20100160324A1 (en) * 2004-12-30 2010-06-24 Astex Therapeutics Limited Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
CN101146533A (zh) * 2005-01-21 2008-03-19 阿斯泰克斯治疗有限公司 吡唑激酶抑制剂和其它抗肿瘤剂的组合
AR052660A1 (es) * 2005-01-21 2007-03-28 Astex Therapeutics Ltd Derivados de pirazol para inhibir la cdk's y gsk's
EP1683796A1 (en) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridines, their preparation and their medical use
FR2947546B1 (fr) * 2009-07-03 2011-07-01 Sanofi Aventis Derives de pyrazoles, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AU2007327423A1 (en) 2008-06-05
PL2091920T3 (pl) 2015-04-30
EP2091920A2 (fr) 2009-08-26
IL198328A0 (en) 2010-02-17
CN101553473A (zh) 2009-10-07
TW200829556A (en) 2008-07-16
US20110237801A1 (en) 2011-09-29
EA019454B1 (ru) 2014-03-31
ECSP099312A (es) 2009-06-30
CN101553473B (zh) 2013-06-05
JP5538893B2 (ja) 2014-07-02
FR2908409A1 (fr) 2008-05-16
DOP2009000088A (es) 2013-06-15
KR20090083456A (ko) 2009-08-03
WO2008065282A2 (fr) 2008-06-05
MA30972B1 (fr) 2009-12-01
FR2908409B1 (fr) 2009-01-09
EA200970472A1 (ru) 2009-10-30
HK1137988A1 (en) 2010-08-13
SI2091920T1 (sl) 2015-02-27
NO20091990L (no) 2009-06-02
US20090291984A1 (en) 2009-11-26
PE20081162A1 (es) 2008-10-02
CY1116000T1 (el) 2017-01-25
AU2007327423B2 (en) 2012-09-06
ZA200903560B (en) 2010-08-25
CO6190516A2 (es) 2010-08-19
UY30707A1 (es) 2008-07-03
PT2091920E (pt) 2015-02-05
AR063638A1 (es) 2009-02-04
NZ576709A (en) 2011-08-26
WO2008065282A3 (fr) 2008-07-31
BRPI0718999A2 (pt) 2014-02-25
HRP20150070T1 (hr) 2015-02-27
ES2528385T3 (es) 2015-02-09
NI200900078A (es) 2010-01-27
MX2009004983A (es) 2009-05-22
CL2007003251A1 (es) 2009-08-07
US8420824B2 (en) 2013-04-16
US20110237641A1 (en) 2011-09-29
SV2009003253A (es) 2009-10-27
UA97965C2 (ru) 2012-04-10
US7989439B2 (en) 2011-08-02
CA2667846A1 (fr) 2008-06-05
CR10749A (es) 2009-07-23
US8410286B2 (en) 2013-04-02
EP2091920B1 (fr) 2014-10-22
TN2009000155A1 (fr) 2010-10-18
DK2091920T3 (en) 2015-01-26
JP2010509297A (ja) 2010-03-25
PE20121152A1 (es) 2012-09-07
MY147502A (en) 2012-12-14

Similar Documents

Publication Publication Date Title
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
HN2003000094A (es) Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
HN2009000856A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
PA8671301A1 (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
HN2006000668A (es) Compuestos de quinolina heteroaromaticos
UY31274A1 (es) Composiciones de recubrimiento electrodepositable que contiene una guanidina ciclica
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
DOP2012000038A (es) Conjugados de dímeros de pirrolo [1,4] benzodiazepina como agentes anticancerosos
UA107791C2 (en) Pesticidal compositions
UY31688A1 (es) Plaguicidas
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
HN2008001723A (es) Nitrilos espirociclicos como inhibidores de proteasa
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
PA8604401A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
GT200500130A (es) Forma cristalina alfa del ranelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
UY32101A (es) Compuestos de triazol, su uso, así como productos que los contienen
CR9231A (es) Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
NI201000139A (es) ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE